N8 Medical, LLC (N8 Medical) is a clinical-stage medical device company focused on commercializing medical devices that incorporate a novel class of active compounds called ceragenins.
These proprietary ceragenin compounds impart unique properties to devices, including antimicrobial, anti-inflammatory and immunomodulatory properties, among others. Ceragenin-based medical devices are designed to address the multibillion dollar public health and economic burden associated with device-related infections and other complications associated with medical devices.
N8 Medical’s premium CeraShield™ technology is designed to transform ordinary medical devices into high value medical device-drug combination products that provide preventative and therapeutic benefits intended to improve patient outcomes and lower the overall cost of care. N8 Medical believes that ceragenins offer unparalleled efficacy and cost advantages to prevent device-related infections and complications. The use of ceragenins as a platform technology under its CeraShield™ brand across numerous device segments is anticipated to provide N8 Medical with a unique, sustainable competitive advantage over other medical device companies. Additional information regarding N8 Medical’s CeraShield™ devices be found on the Pipeline page.
Ceragenins are synthetic, non-peptide small molecule mimetics of endogenous host defense peptides known as cathelicidins. Ceragenins can have multiple biological functions mimicking those of endogenous host defense peptides despite being synthetic small molecules, including antimicrobial, anti-inflammatory, immunomodulatory and wound healing properties. Additional information regarding ceragenins can be found on the Technology page.